Key Takeaways A federal push to modernize cannabis policy should prioritize clinical delivery models, not only access, given widespread patient use without standardized dispensing or medication management. Canada’s system relied on nonprescription authorizations lacking dosing and formulation standards, while mandating direct-to-producer purchasing, effectively removing pharmacists from routine patient care. SHOW MORE Canada’s experience demonstrates the […]